| Literature DB >> 29150010 |
Jaime L Palmer-Hague1, Vivian Tsang2, Charlenn Skead3, Richard J Wassersug4, Eleni Nasiopoulos5, Alan Kingstone5.
Abstract
INTRODUCTION: Testosterone is known to regulate male sexual interest, but the exact way that androgens influence men's sexual cognition remains unclear. AIM: To investigate the influence of androgen deprivation (AD) on visual responses to sexually suggestive stimuli in men treated for prostate cancer with AD therapy.Entities:
Keywords: Androgen Deprivation; Cognition; Eye Tracking; Sexual Desire; Testosterone; Visual Attention
Year: 2017 PMID: 29150010 PMCID: PMC5693430 DOI: 10.1016/j.esxm.2017.10.001
Source DB: PubMed Journal: Sex Med ISSN: 2050-1161 Impact factor: 2.491
Figure 1Representative of male and female fully clothed and minimally clothed image pairs.
Figure 2Geographic AOIs analyzed for proportion of fixations made to the images. AOIs = areas of interest; FC = fully clothed; MC = minimally clothed.
Descriptive statistics for psychological and health questionnaire scores
| Measure | AD | No-AD | HC | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||
| FACT-G | 83.29 | 12.44 | 84.17 | 12.97 | 71.32 | 19.01 | .16 |
| EPIC domains | |||||||
| Urinary function | 93.37 | 6.84 | 77.27 | 19.55 | 90.30 | 13.61 | .08 |
| Urinary bother | 81.25 | 20.00 | 63.99 | 26.40 | 77.38 | 12.09 | .21 |
| Bowel function | 84.38 | 34.26 | 86.91 | 7.96 | 89.05 | 9.76 | .91 |
| Bowel bother | 85.72 | 25.61 | 82.44 | 17.06 | 88.69 | 9.15 | .80 |
| Sexual function | 4.75 | 10.27 | 31.87 | 23.95 | 30.87 | 27.32 | .03 |
| Sexual bother | 28.91 | 39.67 | 54.17 | 34.27 | 50.00 | 45.59 | .36 |
| Hormonal function | 81.43 | 18.64 | 87.50 | 13.29 | 89.17 | 12.81 | .60 |
| Hormonal bother | 79.17 | 22.82 | 92.01 | 8.97 | 88.20 | 11.31 | .19 |
| SHIM | 5.38 | 2.20 | 12.00 | 7.60 | 14.00 | 4.47 | .02 |
| CES-D | 7.13 | 7.51 | 9.31 | 5.54 | 13.14 | 11.10 | .33 |
AD = prostate cancer with androgen deprivation therapy; CES-D = Center for Epidemiologic Studies Depression Scale; EPIC = Expanded Prostate Cancer Index Composite; FACT-G = Functional Assessment of Cancer Therapy General; HC = healthy control; No-AD = prostate cancer without androgen deprivation therapy; SHIM = Sexual Health Inventory for Men.
Statistically significant.
Figure 3Interaction effect of group (AD vs NoAD) by image type (FC vs MC) on proportion of fixations to the images. AD = prostate cancer with androgen deprivation therapy; FC = fully clothed; MC = minimally clothed; NoAD = prostate cancer without androgen deprivation therapy.
Descriptive statistics for proportion of fixations to leg, chest, groin, and face regions for MC and FC images
| Group | MC | FC | ||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| Legs | ||||
| AD | 0.11 | 0.06 | 0.11 | 0.09 |
| No-AD | 0.17 | 0.12 | 0.19 | 0.11 |
| HC | 0.12 | 0.08 | 0.13 | 0.08 |
| Chest | ||||
| AD | 0.33 | 0.09 | 0.32 | 0.12 |
| No-AD | 0.34 | 0.10 | 0.39 | 0.15 |
| HC | 0.38 | 0.19 | 0.36 | 0.18 |
| Pelvis | ||||
| AD | 0.27 | 0.06 | 0.17 | 0.04 |
| No-AD | 0.32 | 0.10 | 0.19 | 0.11 |
| HC | 0.23 | 0.08 | 0.12 | 0.04 |
| Face | ||||
| AD | 0.29 | 0.10 | 0.41 | 0.15 |
| No-AD | 0.17 | 0.11 | 0.23 | 0.13 |
| HC | 0.27 | 0.11 | 0.39 | 0.12 |
AD = prostate cancer with androgen deprivation therapy; FC = fully clothed; HC = healthy control; MC = minimally clothed; No-AD = prostate cancer without androgen deprivation therapy.